InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-4.4%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by WORBOYS PHILIP D, Vice-Président Senior, Recherche et Science Translational. Director active across 1 company, notably Theravance Biopharma, Inc.. In total, 6 reports have been recorded. History available since 20 May 2021. The latest transaction was disclosed on 19 November 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
4,310 shares@ US$8.360.0038% mcap10.8% of flowOrdinary SharesSEC:0001415889-21-005465:0
4,310 shares@ US$8.3610.8% of flowOrdinary SharesSEC:0001415889-21-005465
4,307 shares@ US$14.050.0062% mcap17.7% of flowOrdinary SharesSEC:0001179110-21-008406:0
4,307 shares@ US$14.0517.7% of flowOrdinary SharesSEC:0001179110-21-008406
4,310 shares@ US$17.8021.5% of flowOrdinary SharesSEC:0001179110-21-005854
4,310 shares@ US$17.800.0075% mcap21.5% of flowOrdinary SharesSEC:0001179110-21-005854:0
6 of 6 declarations
About WORBOYS PHILIP D
Philip D. Worboys is the Senior Vice President of Research & Translational Science at Theravance Biopharma, Inc. He is responsible for leading the company's research and development initiatives. Philip plays a key role in scientific innovation and the implementation of new therapies. His expertise in the pharmaceutical field contributes to Theravance's mission of improving patients' lives.
